Literature DB >> 23096084

Molecular cloning and expression of 17β-hydroxysteroid dehydrogenase type 2 gene in Hu sheep.

Chang Long Wang1, Shi Jia Ying, Zi Yu Wang, Hui Jun Xing, Li Zhong Wang, Dong Yang He, Shen Hua Xiao, Feng Wang.   

Abstract

17β-Hydroxysteroid dehydrogenase type 2 (17β-HSD2) catalyzes the NADP+-dependent oxidation of the most potent estrogen 17β-estradiol into the weak estrogen estrone, and the conversion of testosterone to androstenedione. It has been reported that 17β-HSD2 was expressed in many tissues in human, rats, however, the full-length sequence of 17β-HSD2 gene and its expression in ewe were still unknown. In this study, we cloned the full-length cDNA sequence and investigated mRNA differential expression in 28 tissues of 12 adult Hu-Sheep which were fed with high- and low- dietary intake. The 1,317 bp full-length cDNA sequence was first cloned. The coding region was 1,167 bp in length, and the monomer was estimated to contain 389 amino acid residues. It shares high AA sequence identity with that of bos Taurus (96.13 %), sus scrofa (77.06 %), canis lupus familiaris (70.44 %), Callithrix jacchus (65.72 %), Nomascus leucogenys (65.46 %), pan troglodytes (65.21 %), human (64.69 %), mus musculus (58.35 %), and a comparatively lower identity to danio rerio (37.85 %). 17β-HSD2 gene was high expressed in gastrointestinal (GI) tract, liver, but weakly expressed in other tissues. No detected expression was examined in lung. 17β-HSD2 gene expression was significantly difference in rumen, omasum, duodenum, cecum, hypophysis after high- and low- dietary intake. Results from the present study suggested that 17β-HSD2 plays a crucial role in almost all tissues protecting against excessive levels of active steroid hormone, and GI tract maybe an important steroid hormone metabolizing organ in Hu-Sheep. This present study is the first to provide the primary foundation for further insight into this ovine gene.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23096084     DOI: 10.1007/s11033-012-2149-z

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  22 in total

Review 1.  Design and validation of specific inhibitors of 17beta-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis.

Authors:  Joanna M Day; Helena J Tutill; Atul Purohit; Michael J Reed
Journal:  Endocr Relat Cancer       Date:  2008-06-09       Impact factor: 5.678

2.  Developmental changes in lysophospholipid receptor expression in rodent heart from near-term fetus to adult.

Authors:  Fang Wang; Jianfeng Hou; Bianmei Han; Yu Nie; Xiangfeng Cong; Shengshou Hu; Xi Chen
Journal:  Mol Biol Rep       Date:  2012-06-28       Impact factor: 2.316

3.  Metabolism of testosterone and androstenedione by human adult and fetal gastrointestinal tissues in vitro.

Authors:  W Nienstedt; M Ahotupa; E Hietanen
Journal:  J Steroid Biochem       Date:  1980-12       Impact factor: 4.292

4.  Mouse 17 beta-hydroxysteroid dehydrogenase type 2 mRNA is predominantly expressed in hepatocytes and in surface epithelial cells of the gastrointestinal and urinary tracts.

Authors:  M V Mustonen; M H Poutanen; S Kellokumpu; Y de Launoit; V V Isomaa; R K Vihko; P T Vihko
Journal:  J Mol Endocrinol       Date:  1998-02       Impact factor: 5.098

Review 5.  Physiology and molecular genetics of 17 beta-hydroxysteroid dehydrogenases.

Authors:  S Andersson; N Moghrabi
Journal:  Steroids       Date:  1997-01       Impact factor: 2.668

6.  A useful cell system for studying the regulation of 17HSD/KSR type 2 activity and expression in ovarian epithelial cancer.

Authors:  Pierre R Provost; Paul H Lima; Yves Tremblay; Charles H Blomquist
Journal:  J Steroid Biochem Mol Biol       Date:  2010-06-17       Impact factor: 4.292

7.  Loss of estrogen inactivation in colonic cancer.

Authors:  M A English; K F Kane; N Cruickshank; M J Langman; P M Stewart; M Hewison
Journal:  J Clin Endocrinol Metab       Date:  1999-06       Impact factor: 5.958

8.  Characterisation of estrogenic 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity in the human brain.

Authors:  Stephan Steckelbroeck; Matthias Watzka; Annette Reissinger; Petra Wegener-Toper; Frank Bidlingmaier; Niklaas Bliesener; Volkmar H J Hans; Hans Clusmann; Michael Ludwig; Lothar Siekmann; Dietrich Klingmüller
Journal:  J Steroid Biochem Mol Biol       Date:  2003-07       Impact factor: 4.292

9.  Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol.

Authors:  K Zeitoun; K Takayama; H Sasano; T Suzuki; N Moghrabi; S Andersson; A Johns; L Meng; M Putman; B Carr; S E Bulun
Journal:  J Clin Endocrinol Metab       Date:  1998-12       Impact factor: 5.958

10.  Oestrogen inactivation in the colon: analysis of the expression and regulation of 17beta-hydroxysteroid dehydrogenase isozymes in normal colon and colonic cancer.

Authors:  M A English; S V Hughes; K F Kane; M J Langman; P M Stewart; M Hewison
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

View more
  2 in total

1.  Transcriptomic Analysis of Ovaries from Pigs with High And Low Litter Size.

Authors:  Xiaodong Zhang; Long Huang; Tao Wu; Yifang Feng; Yueyun Ding; Pengfei Ye; Zongjun Yin
Journal:  PLoS One       Date:  2015-10-01       Impact factor: 3.240

Review 2.  Estrogen Formation and Inactivation Following TBI: What we Know and Where we Could go.

Authors:  Kelli A Duncan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-29       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.